Impact of HLA Alleles on Outcomes of Allogeneic Transplantation for B Cell Non-Hodgkin Lymphomas: A Center for International Blood and Marrow Transplant Research Analysis
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Apr 01, 2018
- Source ID
- 10.1016/j.bbmt.2017.11.003
Entities
People
- Basem M. William
- Brian T. Hill
- Katharina Fleischhauer
- Katharine C Hsu
- Marcelo Fernandez-viña
- Marcos J. De Lima
- Michael D. Haagenson
- Michael R Verneris
- Stephanie J. Lee
- Stephen R. Spellman
- Tao Wang
Organizations
- Actinium Pharmaceuticals (United States)
- Amgen
- Angiocrine Bioscience (United States)
- Astellas Pharma (United States)
- AstraZeneca (United States)
- Atara Biotherapeutics, Inc.
- Bristol-Myers Squibb
- Celgene
- Fred Hutchinson Cancer Center
- Genzyme
- Gilead Sciences
- Health Resources and Services Administration
- Incyte
- Janssen Scientific Affairs (United States)
- Jazz Pharmaceuticals
- Kite Pharma
- Medical College of Wisconsin
- Merck & Co.
- National Cancer Institute
- National Heart, Lung, and Blood Institute
- National Institute of Allergy and Infectious Diseases
- National Marrow Donor Program
- Office of Naval Research
- Patient-Centered Outcomes Research Institute
- Pfizer
- Seagen
- Shire plc
- St. Baldrick's Foundation
- Swedish Orphan Biovitrum
- Takeda Oncology
- University of Minnesota